The latest closing stock price for Y-mAbs Therapeutics as of January 31, 2025 is 5.97.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-751 today, roughly -1 times their original investment - a -20.70% compound annual growth rate over 6 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 20.90, which is 250.1% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 5.92, which is 0.8% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 12.75.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-751 today, roughly -1 times their original investment - a -20.70% compound annual growth rate over 6 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 20.90, which is 250.1% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 5.92, which is 0.8% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 12.75.